AGL - NYSE
Agilon Health, Inc.
$82.70
-11%agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
At a Glance
Live SnapshotAgilon Health, Inc. Management Team
Ms. Denise Zamore
Chief Legal Officer & Secretary
Mr. Benjamin Shaker
Chief Markets Officer
Compensation
$602,771
Mr. Mat Varghese
Chief People Officer
Mr. Girish Venkatachaliah
Chief Technology Officer
Compensation
$560,888
Mr. Bill Farry
Chief of Technology Innovation
Mr. Jeffrey Alan Schwaneke CPA
Executive Vice President & Chief Financial Officer
Compensation
$1,000,367
Mr. Kenny Bellendir
Markets Chief Financial Officer
Mr. Steven Jackson Sell
President, Chief Executive Officer & Director
Compensation
$916,034
Leland Thomas
Senior Manager of Investor Relations
Mr. Timothy Gertsch
Vice President, Controller & Chief Accounting Officer
Agilon Health, Inc. Insider Positioning
During the last 12 months, insiders have purchased $352K and sold $112K worth of AGL shares, resulting in $240K of net buying activity.
3 Months
0
0.00
0
0.00
+0
+$0
3-6 Months
500.0K
301.05K
0
0.00
+301K
+$301K
6-9 Months
81.0K
50.94K
0
0.00
+51K
+$51K
9-12 Months
0
0.00
47.4K
111.72K
-112K
-$112K
Top Buyers
Shaker Benjamin
Officer: Chief Markets Officer
$301K
Wulf John William
Director
$51K
Top Sellers
Schwaneke Jeffrey A.
Officer: Chief Financial Officer
$110K
Zamore Denise
Officer: Chief Legal Officer
$2K
Gertsch Timothy
Officer: Chief Accounting Officer
$450
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $240K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Exceptional buy/sell ratio. Buying dramatically outweighs selling—one of the strongest possible insider signals.
Insider Participation
3 insider sellers vs. 2 buyers. More insiders selling than buying suggests cautious or negative sentiment.
Insider Activity Insight
Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.
SEC Filings
AGL - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 22, 2026 | June 02, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | February 18, 2026 | March 17, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 17, 2025 | May 28, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 18, 2024 | May 29, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 14, 2023 | April 14, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 11, 2022 | May 24, 2022 | 2022 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.